Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $7.04 billion. The enterprise value is $10.16 billion.
| Market Cap | 7.04B |
| Enterprise Value | 10.16B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 348.30 million shares outstanding. The number of shares has increased by 4.13% in one year.
| Current Share Class | 348.30M |
| Shares Outstanding | 348.30M |
| Shares Change (YoY) | +4.13% |
| Shares Change (QoQ) | +2.33% |
| Owned by Insiders (%) | 38.19% |
| Owned by Institutions (%) | 48.36% |
| Float | 215.21M |
Valuation Ratios
The trailing PE ratio is 50.64 and the forward PE ratio is 18.66. AMRX's PEG ratio is 2.07.
| PE Ratio | 50.64 |
| Forward PE | 18.66 |
| PS Ratio | 2.20 |
| Forward PS | 2.10 |
| PB Ratio | 12.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 183.20 |
| P/OCF Ratio | 38.97 |
| PEG Ratio | 2.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.75, with an EV/FCF ratio of 264.54.
| EV / Earnings | 76.25 |
| EV / Sales | 3.18 |
| EV / EBITDA | 13.75 |
| EV / EBIT | 18.63 |
| EV / FCF | 264.54 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 5.12.
| Current Ratio | 1.87 |
| Quick Ratio | 1.05 |
| Debt / Equity | 5.12 |
| Debt / EBITDA | 4.32 |
| Debt / FCF | 85.44 |
| Interest Coverage | 2.44 |
Financial Efficiency
Return on equity (ROE) is 70.00% and return on invested capital (ROIC) is 15.77%.
| Return on Equity (ROE) | 70.00% |
| Return on Assets (ROA) | 7.69% |
| Return on Invested Capital (ROIC) | 15.77% |
| Return on Capital Employed (ROCE) | 13.15% |
| Weighted Average Cost of Capital (WACC) | 9.52% |
| Revenue Per Employee | $367,324 |
| Profits Per Employee | $15,322 |
| Employee Count | 8,700 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, AMRX has paid $11.97 million in taxes.
| Income Tax | 11.97M |
| Effective Tax Rate | 5.40% |
Stock Price Statistics
The stock price has increased by +86.78% in the last 52 weeks. The beta is 1.22, so AMRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +86.78% |
| 50-Day Moving Average | 19.22 |
| 200-Day Moving Average | 15.81 |
| Relative Strength Index (RSI) | 51.10 |
| Average Volume (20 Days) | 3,946,394 |
Short Selling Information
The latest short interest is 14.07 million, so 4.04% of the outstanding shares have been sold short.
| Short Interest | 14.07M |
| Short Previous Month | 11.28M |
| Short % of Shares Out | 4.04% |
| Short % of Float | 6.54% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
In the last 12 months, AMRX had revenue of $3.20 billion and earned $133.30 million in profits. Earnings per share was $0.40.
| Revenue | 3.20B |
| Gross Profit | 1.28B |
| Operating Income | 545.52M |
| Pretax Income | 221.46M |
| Net Income | 133.30M |
| EBITDA | 739.00M |
| EBIT | 545.52M |
| Earnings Per Share (EPS) | $0.40 |
Balance Sheet
The company has $157.40 million in cash and $3.28 billion in debt, with a net cash position of -$3.13 billion or -$8.97 per share.
| Cash & Cash Equivalents | 157.40M |
| Total Debt | 3.28B |
| Net Cash | -3.13B |
| Net Cash Per Share | -$8.97 |
| Equity (Book Value) | 640.71M |
| Book Value Per Share | 1.58 |
| Working Capital | 975.18M |
Cash Flow
In the last 12 months, operating cash flow was $180.63 million and capital expenditures -$142.20 million, giving a free cash flow of $38.42 million.
| Operating Cash Flow | 180.63M |
| Capital Expenditures | -142.20M |
| Depreciation & Amortization | 193.48M |
| Net Borrowing | 511.86M |
| Free Cash Flow | 38.42M |
| FCF Per Share | $0.11 |
Margins
Gross margin is 40.07%, with operating and profit margins of 17.07% and 4.17%.
| Gross Margin | 40.07% |
| Operating Margin | 17.07% |
| Pretax Margin | 6.93% |
| Profit Margin | 4.17% |
| EBITDA Margin | 23.12% |
| EBIT Margin | 17.07% |
| FCF Margin | 1.20% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.13% |
| Shareholder Yield | -4.13% |
| Earnings Yield | 1.97% |
| FCF Yield | 0.55% |
Analyst Forecast
The average price target for AMRX is $23.43, which is 15.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.43 |
| Price Target Difference | 15.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 8.54% |
| EPS Growth Forecast (3Y) | 20.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |